Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Tegzová · SciRah

Researcher profile · Semantic Scholar

D. Tegzová

Share profile

D. Tegzová — researcher profile on SciRah

h-index: 18
Works: 32
Citations: 2,890

Most-cited papers

A Phase 3, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits BLyS, in Patients With Systemic Lupus Erythematosus
R. Furie, M. Petri, O. Zamani, R. Cervera +12 more
2011Arthritis & Rheumatism1,513 citations Open access
Semantic Scholar
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.
D. M. van der Heijde, Yoshiya Tanaka, R. Fleischmann, E. Keystone +15 more
2013Arthritis & Rheumatism567 citations
Semantic Scholar
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study
J. Závada, S. Pešičková, R. Ryšavá, M. Olejárová +13 more
2010Lupus117 citations
Semantic Scholar
Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial
W. Chatham, Daniel J. Wallace, W. Stohl, K. Latinis +10 more
2012Journal of Rheumatology98 citations Open access
Semantic Scholar
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study
D. van der Heijde, V. Strand, Yoshiya Tanaka, E. Keystone +11 more
2019Arthritis & Rheumatology94 citations Open access
Semantic Scholar
Effect of 1 year cyclosporine a treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study
C. Dostal, V. Tesar, I. Rychlík, J. Žabka +4 more
1998Lupus66 citations
Semantic Scholar
IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis
A. Navrátilová, Lucie Andrés Cerezo, H. Hulejová, V. Bečvář +9 more
2021Frontiers in Immunology53 citations Open access
Semantic Scholar
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.
S. Sheikh, M. Scheinberg, J. Wei, D. Tegzová +20 more
2020The Lancet Rheumatology46 citations
Semantic Scholar
Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus
J. Závada, Petra Nytrova, K. Wandinger, S. Jarius +6 more
2011Rheumatology International41 citations
Semantic Scholar
Association of systemic lupus erythematosus with low serum bilirubin levels
L. Vítek, L. Muchová, E. Jančová, S. Pešičková +5 more
2010Scandinavian Journal of Rheumatology40 citations
Semantic Scholar
Seronegative Lyme Arthritis caused by Borrelia garinii
H. Dejmková, D. Hulínská, D. Tegzová, K. Pavelka +2 more
2002Clinical Rheumatology39 citations
Semantic Scholar
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries.
Eleana Bolla, A. Semb, A. Kerola, E. Ikdahl +39 more
2024The Lancet Rheumatology32 citations Open access
Semantic Scholar
BELIMUMAB, A BLYS-SPECIFIC INHIBITOR, REDUCES DISEASE ACTIVITY AND SEVERE FLARES IN SEROPOSITIVE SLE PATIENTS
R. van Vollenhoven, O. Zamani, D. Wallace, D. Tegzová +17 more
201132 citations
Semantic Scholar
Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A
J. Závada, S. Pešičková, R. Ryšavá, P. Horák +13 more
2014Lupus31 citations
Semantic Scholar
Tofacitinib (CP-690,550), an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-month Phase 3 Study
D. van der Heijde, C. Zerbini, M. Cardiel, S. Cohen +11 more
201122 citations
Semantic Scholar
Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.
M. Mišunová, T. Svitálková, L. Pleštilová, O. Kryštůfková +11 more
2017Clinical and Experimental Rheumatology20 citations
Semantic Scholar
HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population
M. Fojtíková, P. Novota, P. Čejková, S. Pešičková +2 more
2011Rheumatology International20 citations Open access
Semantic Scholar
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
V. Strand, D. M. van der Heijde, Yoshiya Tanaka, E. Keystone +11 more
2019Clinical and Experimental Rheumatology18 citations
Semantic Scholar
Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment.
K. Pavelka, J. Gatterová, D. Tegzová, K. Jarošová +5 more
2007Clinical and Experimental Rheumatology18 citations
Semantic Scholar
Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus.
L. Podrazilová, V. Peterová, M. Olejárová, D. Tegzová +4 more
2008Clinical and Experimental Rheumatology10 citations
Semantic Scholar
LB0012 HEADLINE RESULTS FOR A PHASE 4, 52-WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS ADVERSE EVENTS OF SPECIAL INTEREST (AESI) IN ADULTS WITH ACTIVE, AUTOANTIBODY-POSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) RECEIVING BELIMUMAB
S. Sheikh, M. Scheinberg, James Cheng-Chung Wei, D. Tegzová +10 more
2019Oral Presentations6 citations Open access
Semantic Scholar
SAT0188 Early clinical improvement in SLE patients treated with belimumab
A. Doria, J. Sánchez-Guerrero, D. Tegzová, E. Ginzler +3 more
20132 citations
Semantic Scholar
POS0712 YEAR-4 OBSERVATIONAL FOLLOW-UP OF BELIMUMAB SAFETY (MORTALITY AND MALIGNANCIES) IN PATIENTS WITH SLE WHO COMPLETED A PHASE 4, 52-WEEK, RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED SAFETY STUDY
S. Sheikh, M. Scheinberg, J.-C.-C. Wei, D. Tegzová +15 more
2022Annals of the Rheumatic Diseases1 citations Open access
Semantic Scholar
AB0288 SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: YEAR 2 FOLLOW-UP OF A LARGE PHASE 4, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
S. Sheikh, M. Scheinberg, J. Wei, D. Tegzová +11 more
20211 citations Open access
Semantic Scholar
FRI0262 Differences in serum microrna profile in active systemic lupus erythematosus and healthy controls
M. Fojtíková, R. Svobodová, D. Tegzová, J. Závada +6 more
20131 citations
Semantic Scholar
2.6 Systemic lupus erythematosus, Sjogren's and antiphospholipid syndrome – therapies
M. Petri, J. Sánchez-Guerrero, D. Tegzová, E. Ginzler +13 more
20121 citations
Semantic Scholar
POS0388 INTERLEUKIN 40 (IL-40) IS UP-REGULATED IN RHEUMATOID ARTHRITIS (RA) AND ASSOCIATED WITH DISEASE ACTIVITY, LEVELS OF AUTOANTIBODIES AND CHEMOKINES
A. Navrátilová, L. A. Cerezo, H. Hulejová, V. Bečvář +6 more
20210 citations
Semantic Scholar
SAT0025 Pregnancy Outcomes in A Cohort of Women with Sle. Long Term 20 Years Observation
D. Tegzová, K. Andelova, I. Kučerová, J. Madar +5 more
20140 citations
Semantic Scholar
FRI0135 Baseline characteristics and twelve month outcomes of patients from the prague early rheumatoid arhritis clinic
H. Mann, O. Růžičková, O. Šléglová, M. Fojtíková +3 more
20130 citations
Semantic Scholar
THU0280 Extended Follow-Up of the Cyclofa-Lune Trial Comparing Two Sequential Induction and Maintenance Treatment Regimens for Proliferative Lupus Nephritis Based Either on Cyclophosphamide or Cyclosporine a
J. Závada, S. Pešičková, R. Ryšavá, P. Horák +9 more
20130 citations
Semantic Scholar
FRI0030 Higher levels of serum interleukin-20 are associated with better response to disease-modifying antirheumatic drugs in patients with resent-onset rheumatoid arthritis
B. Šumová, H. Hulejová, H. Mann, D. Tegzová +11 more
20130 citations
Semantic Scholar
O49 The pregnancy outcome in patients with systemic connective tissue disease
K. Andelova, I. Kučerová, D. Tegzová
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Závada×7
Invite
J. Závada — researcher profile on SciRah
W. Stohl×6
Invite
W. Stohl — researcher profile on SciRah
J. Vencovský×6
Invite
J. Vencovský — researcher profile on SciRah
Z. Zhong×5
Invite
Z. Zhong — researcher profile on SciRah

S. Pešičková

×5

Invite

S. Pešičková — researcher profile on SciRah

Invite

V. Tesar — researcher profile on SciRah

J. Sánchez-Guerrero×4

Invite

J. Sánchez-Guerrero — researcher profile on SciRah

Invite

C. Zerbini — researcher profile on SciRah

Invite

P. Nash — researcher profile on SciRah

Invite

D. Gruben — researcher profile on SciRah

G. Wallenstein×4

Invite

G. Wallenstein — researcher profile on SciRah

Invite

C. Connell — researcher profile on SciRah